التأثير التآزري الوقائي لمشاركة خلاصة شوكة الحليب وفيتامين C ضد السمية الكبدية المحدثة بالباراسيتامول لدى الأرانب

اليسع رستناوي; خالد كريج; هيا المحيميد; هدى شما; سدرة شلب الشام

doi:10.5281/zenodo.20266953

Authors

Dr. Alyasaa Rastanawi Al Wataniya Private University
Dr. Khaled Krej Al Wataniya Private University
Haya Al-mhaymed Al Wataniya Private University
Huda Shamma Al Wataniya Private University
Sidra Shalab-alsham Al Wataniya Private University

DOI:

https://doi.org/10.5281/zenodo.20266953

Keywords:

Hepatotoxicity, Silybum Marianum, Vitamin C, Oxidative Stress, Liver Enzymes

Abstract

Objectives: Drug-induced hepatotoxicity, particularly resulting from paracetamol overdose, is a major cause of acute liver injury. Silybum Marianum plant has a well-known hepatoprotective effect due to its antioxidant and anti-inflammatory properties. Vitamin C has very strong antioxidant properties. Thus, this study aimed to investigate the protective effect of Silybum Marianum extract and vitamin C combination on paracetamol-induced hepatotoxicity in rabbits.

Materials and Methods: 16 male rabbits were divided into 4 groups (n = 4 each): (1) Control group (CTRL), (2) diseased group (PARA), (3) first treatment group (SLM), and (4) second treatment group (combination) (SLM+VITC). Hepatotoxicity was assessed by measuring serum ALT and AST levels and liver histopathology.

Results: Paracetamol caused significant increase in ALT and AST compared to control group (p<0.05). Treatment with the extract alone improved the histological picture and decreased liver enzymes, while the combination treatment showed a greater decrease in enzymes levels.

Conclusion: The proposed combination treatment provided greater hepatoprotection compared to the extract alone, with a greater decrease in liver enzymes, indicating a synergetic effect

Downloads

Download data is not yet available.

References

[1] A. I. Shehu, X. Ma, and R. Venkataramanan, “Mechanisms of drug-induced hepatotoxicity,” Clinics in Liver Disease, vol. 21, no. 1, pp. 35–54, 2017.

[2] R. Vuppalanchi and M. Ghabril, “Clinical assessment of suspected drug-induced liver injury and its management,” Alimentary Pharmacology & Therapeutics, vol. 56, no. 11–12, pp. 1516–1531, 2022.

[3] F. W. Franco and M. C. Malonn, “Acetaminophen pharmacokinetic and toxicological aspects: A review,” Revista Científica Multidisciplinar Núcleo do Conhecimento, vol. 12, pp. 18–27, 2021.

[4] A. Beltrán-Olazábal, P. Martínez-Galán, R. Castejón-Moreno, M. E. García-Moreno, C. García-Muro, and E. Esteban-Zubero, “Management of acetaminophen toxicity: A review,” Iberoamerican Journal of Medicine, vol. 1, no. 1, pp. 22–28, 2019.

[5] E. Yoon, A. Babar, M. Choudhary, M. Kutner, and N. Pyrsopoulos, “Acetaminophen-induced hepatotoxicity: A comprehensive update,” Journal of Clinical and Translational Hepatology, vol. 4, no. 2, p. 131, 2016.

[6] K. Wadhwa et al., “Mechanistic insights into the pharmacological significance of silymarin,” Molecules, vol. 27, no. 16, Art. no. 5327, 2022.

[7] C. Hellerbrand, J. M. Schattenberg, P. Peterburs, A. Lechner, and R. Brignoli, “The potential of silymarin for the treatment of hepatic disorders,” Clinical Phytoscience, vol. 2, no. 1, p. 7, 2016.

[8] H. M. Jaffar, F. Al-Asmari, F. A. Khan, M. A. Rahim, and E. Zongo, “Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review,” Food Science & Nutrition, vol. 12, no. 5, pp. 3097–3111, 2024.

[9] C. R. de Avelar, E. M. Pereira, P. R. de Farias Costa, R. P. de Jesus, and L. P. M. de Oliveira, “Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis,” World Journal of Gastroenterology, vol. 23, no. 27, p. 5004, 2017.

[10] S. P. Tighe, D. Akhtar, U. Iqbal, and A. Ahmed, “Chronic liver disease and silymarin: A biochemical and clinical review,” Journal of Clinical and Translational Hepatology, vol. 8, no. 4, p. 454, 2020.

[11] D. Njus, P. M. Kelley, Y. J. Tu, and H. B. Schlegel, “Ascorbic acid: The chemistry underlying its antioxidant properties,” Free Radical Biology and Medicine, vol. 159, pp. 37–43, 2020.

[12] A. Al-Gareeb and G. F. Mohammed, “Hepatoprotective effects of vitamin C against methotrexate induced acute liver injury: An experimental study,” Bulletin of Pharmaceutical Sciences Assiut University, vol. 45, no. 1, pp. 459–468, 2022.

[13] A. Gęgotek and E. Skrzydlewska, “Antioxidative and anti-inflammatory activity of ascorbic acid,” Antioxidants, vol. 11, no. 10, Art. no. 1993, 2022.

[14] E. Yoon, A. Babar, M. Choudhary, M. Kutner, and N. Pyrsopoulos, “Acetaminophen-induced hepatotoxicity: A comprehensive update,” Journal of Clinical and Translational Hepatology, vol. 4, no. 2, p. 131, 2016.

[15] T. Nazir et al., “Hepatoprotective activity of Foeniculum vulgare against paracetamol induced hepatotoxicity in rabbit,” Journal of Applied Pharmacy, vol. 12, 2020.

[16] N. Mirza, “Paracetamol-induced hepatotoxicity,” in Hepatotoxicity. IntechOpen, 2022.

[17] A. H. Ghonaim et al., “Hepatoprotective and renoprotective effects of silymarin against salinomycin-induced toxicity in adult rabbits,” Veterinary World, vol. 15, no. 9, p. 2244, 2022.

[18] P. F. Surai, A. Surai, and K. Earle-Payne, “Silymarin and inflammation: Food for thoughts,” Antioxidants, vol. 13, no. 1, Art. no. 98, 2024.

[19] A. Thumma et al., “Antioxidant and hepatoprotective effects of Silybum marianum extract,” Biochemical & Cellular Archives, vol. 24, no. 2, 2024.

[20] A. Talebi, R. Soltani, F. Khorvash, and S. M. Jouabadi, “The effectiveness of silymarin in the prevention of anti-tuberculosis drug-induced hepatotoxicity: A randomized controlled clinical trial,” International Journal of Preventive Medicine, vol. 14, no. 1, p. 48, 2023.

[21] P. Xu, Y. Li, Z. Yu, L. Yang, R. Shang, and Z. Yan, “Protective effect of vitamin C on triptolide-induced acute hepatotoxicity in mice through mitigation of oxidative stress,” Anais da Academia Brasileira de Ciências, vol. 91, no. 2, Art. no. e20181257, 2019.

[22] M. Talpur, A. Y. Palli, and S. S. Qureshi, “Drug induced liver injury: Role of ascorbic acid in a laboratory animal,” The Professional Medical Journal, vol. 24, no. 11, pp. 1697–1701, 2017.

[23] A. Salman, D. E. S. El-Ghazouly, and M. El Beltagy, “Role of ascorbic acid versus silymarin in amelioration of hepatotoxicity induced by acrylamide in adult male albino rats: Histological and immunohistochemical study,” International Journal of Morphology, vol. 38, no. 6, 2020.

[24] S. Sabiu, T. O. Sunmonu, E. O. Ajani, and T. O. Ajiboye, “Combined administration of silymarin and vitamin C stalls acetaminophen-mediated hepatic oxidative insults in Wistar rats,” Revista Brasileira de Farmacognosia, vol. 25, no. 1, pp. 29–34, 2015.